GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Centenial Surgical Suture Ltd (BOM:531380) » Definitions » EBIT

Centenial Surgical Suture (BOM:531380) EBIT : ₹8.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Centenial Surgical Suture EBIT?

Centenial Surgical Suture's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was ₹-3.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹8.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Centenial Surgical Suture's annualized ROC % for the quarter that ended in Dec. 2024 was -2.25%. Centenial Surgical Suture's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -2.62%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Centenial Surgical Suture's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 1.26%.


Centenial Surgical Suture EBIT Historical Data

The historical data trend for Centenial Surgical Suture's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centenial Surgical Suture EBIT Chart

Centenial Surgical Suture Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.91 24.99 18.39 21.64 21.99

Centenial Surgical Suture Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.19 -4.43 9.29 6.94 -3.50

Competitive Comparison of Centenial Surgical Suture's EBIT

For the Medical Instruments & Supplies subindustry, Centenial Surgical Suture's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centenial Surgical Suture's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Centenial Surgical Suture's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Centenial Surgical Suture's EV-to-EBIT falls into.


;
;

Centenial Surgical Suture EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centenial Surgical Suture  (BOM:531380) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Centenial Surgical Suture's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-14.208 * ( 1 - 0% )/( (632.403 + 0)/ 1 )
=-14.208/632.403
=-2.25 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=870.687 - 226.747 - ( 11.537 - max(0, 313.703 - 652.314+11.537))
=632.403

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Centenial Surgical Suture's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-14.004/( ( (207.641 + max(327.074, 0)) + (0 + max(0, 0)) )/ 1 )
=-14.004/( ( 534.715 + 0 )/ 1 )
=-14.004/534.715
=-2.62 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(201.22 + 421.355 + 18.202) - (226.747 + 0 + 86.956)
=327.074

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Centenial Surgical Suture's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=8.3/659.555
=1.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centenial Surgical Suture EBIT Related Terms

Thank you for viewing the detailed overview of Centenial Surgical Suture's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Centenial Surgical Suture Business Description

Traded in Other Exchanges
N/A
Address
F-29, MIDC, Murbad, Thane, MH, IND, 421401
Centenial Surgical Suture Ltd is an India-based company engaged in manufacturing, marketing, and selling quality atraumatic needles and sutures; absorbable - synthetic/natural (catgut plain and chromic); non-absorbable sutures; and other medical devices approved and licensed by Food and Drug Administration (FDA). The company's only segment is the manufacturing and sale of Medical Devices. The company sells its products in India and also exports internationally; generating a vast majority of the revenue within India.

Centenial Surgical Suture Headlines

No Headlines